drug · small molecule
patient view →Stem Cell Therapy for Coronavirus Disease 2019 (COVID-19)
Phase 2updated 2mo agoby Stemedica Cell Technologies Inc🔗 ChEMBL
Phase 2community read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 30 approved and 132 investigational indications.
targets
Cyclooxygenase
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that